107 related articles for article (PubMed ID: 7890843)
1. Arabinogalactan-coated superparamagnetic iron oxide: effect of particle size in liver MRI.
Wisner ER; Amparo EG; Vera DR; Brock JM; Barlow TW; Griffey SM; Drake C; Katzberg RW
J Comput Assist Tomogr; 1995; 19(2):211-5. PubMed ID: 7890843
[TBL] [Abstract][Full Text] [Related]
2. Hepatocyte-targeted MR contrast agents: contrast enhanced detection of liver cancer in diffusely damaged liver.
Tanimoto A; Kuribayashi S
Magn Reson Med Sci; 2005; 4(2):53-60. PubMed ID: 16340158
[TBL] [Abstract][Full Text] [Related]
3. The value of fast and ultrafast T2-weighted MR imaging sequences in hepatic enhancement with ferumoxides: comparison with conventional spin-echo sequence.
Abe Y; Yamashita Y; Namimoto T; Tang Y; Takahashi M
Radiat Med; 2000; 18(2):97-105. PubMed ID: 10888042
[TBL] [Abstract][Full Text] [Related]
4. Magnetic resonance imaging of liver metastases: experimental comparison of anionic and conventional superparamagnetic iron oxide particles with a hepatobiliary contrast medium during dynamic and uptake phases.
Kaufels N; Korn R; Wagner S; Schink T; Hamm B; Taupitz M; Schnorr J
Invest Radiol; 2008 Jul; 43(7):496-503. PubMed ID: 18580332
[TBL] [Abstract][Full Text] [Related]
5. Detection of focal liver lesions with superparamagnetic iron oxide: value of STIR and SE imaging.
Halavaara JT; Lamminen AE; Bondestam S; Standertskjöld-Nordenstam CG; Hamberg LM
J Comput Assist Tomogr; 1994; 18(6):897-904. PubMed ID: 7962796
[TBL] [Abstract][Full Text] [Related]
6. Conspicuity of zones of ablation after radiofrequency ablation in porcine livers: comparison of an extracellular and an SPIO contrast agent.
Bangard C; Stippel DL; Berg F; Kasper HU; Hellmich M; Fischer JH; Hölscher A; Lackner K; Gossmann A
J Magn Reson Imaging; 2008 Jul; 28(1):263-70. PubMed ID: 18581392
[TBL] [Abstract][Full Text] [Related]
7. Liver-lesion tissue contrast on MR images: effect of iron oxide concentration and magnetic field strength.
Thickman D; Hendrick RE; Jerjian KA; Schanker CS
Radiology; 1990 Aug; 176(2):557-62. PubMed ID: 2367675
[TBL] [Abstract][Full Text] [Related]
8. Superparamagnetic iron oxide for liver imaging. Comparison among three different preparations.
Bach-Gansmo T; Fahlvik AK; Ericsson A; Hemmingsson A
Invest Radiol; 1994 Mar; 29(3):339-44. PubMed ID: 8175309
[TBL] [Abstract][Full Text] [Related]
9. Hepatocellular lesions with increased iron uptake on superparamagnetic iron oxide-enhanced magnetic resonance imaging in cirrhosis or chronic hepatitis: comparison of four magnetic resonance sequences for lesion conspicuity.
Tanabe M; Ito K; Shimizu A; Fujita T; Onoda H; Yamatogi S; Washida Y; Matsunaga N
Magn Reson Imaging; 2009 Jul; 27(6):801-6. PubMed ID: 19144487
[TBL] [Abstract][Full Text] [Related]
10. Arterioportal shunts in cirrhotic patients: evaluation of the difference between tumorous and nontumorous arterioportal shunts on MR imaging with superparamagnetic iron oxide.
Mori K; Yoshioka H; Itai Y; Okamoto Y; Mori H; Takahashi N; Saida Y
AJR Am J Roentgenol; 2000 Dec; 175(6):1659-64. PubMed ID: 11090400
[TBL] [Abstract][Full Text] [Related]
11. Superparamagnetic iron oxide enhanced magnetic resonance imaging of rat liver with hepatocellular carcinoma and benign hyperplastic nodule.
Ishida T; Murakami T; Kato N; Takahashi M; Miyazawa T; Tsuda K; Tomoda K; Narumi Y; Nakamura H
Invest Radiol; 1997 May; 32(5):282-7. PubMed ID: 9140748
[TBL] [Abstract][Full Text] [Related]
12. Liver tumors in cirrhosis: experimental study with SPIO-enhanced MR imaging.
Clement O; Frija G; Chambon C; Schouman-Clayes E; Mosnier JF; Poupon MF; Balkau B
Radiology; 1991 Jul; 180(1):31-6. PubMed ID: 2052718
[TBL] [Abstract][Full Text] [Related]
13. Hepatic metastases: diffusion-weighted sensitivity-encoding versus SPIO-enhanced MR imaging.
Nasu K; Kuroki Y; Nawano S; Kuroki S; Tsukamoto T; Yamamoto S; Motoori K; Ueda T
Radiology; 2006 Apr; 239(1):122-30. PubMed ID: 16493012
[TBL] [Abstract][Full Text] [Related]
14. Effect of superparamagnetic iron oxide on tumor-to-liver contrast at T2*-weighted gradient-echo MRI: comparison between 3.0T and 1.5T MR systems.
Kim T; Murakami T; Hori M; Onishi H; Tomoda K; Nakamura H
J Magn Reson Imaging; 2009 Mar; 29(3):595-600. PubMed ID: 19243054
[TBL] [Abstract][Full Text] [Related]
15. Benign hepatocellular tumors: MRI after superparamagnetic iron oxide administration.
Grandin C; Van Beers BE; Robert A; Gigot JF; Geubel A; Pringot J
J Comput Assist Tomogr; 1995; 19(3):412-8. PubMed ID: 7790551
[TBL] [Abstract][Full Text] [Related]
16. Superparamagnetic iron oxide-mediated hepatic signal intensity change in patients with and without cirrhosis: pulse sequence effects and Kupffer cell function.
Tanimoto A; Yuasa Y; Shinmoto H; Jinzaki M; Imai Y; Okuda S; Kuribayashi S
Radiology; 2002 Mar; 222(3):661-6. PubMed ID: 11867782
[TBL] [Abstract][Full Text] [Related]
17. Differentiation of well-differentiated hepatocellular carcinomas from other hepatocellular nodules in cirrhotic liver: value of SPIO-enhanced MR imaging at 3.0 Tesla.
Park HS; Lee JM; Kim SH; Chang S; Kim SJ; Han JK; Choi BI
J Magn Reson Imaging; 2009 Feb; 29(2):328-35. PubMed ID: 19161184
[TBL] [Abstract][Full Text] [Related]
18. Receptor imaging: application to MR imaging of liver cancer.
Reimer P; Weissleder R; Lee AS; Wittenberg J; Brady TJ
Radiology; 1990 Dec; 177(3):729-34. PubMed ID: 2243978
[TBL] [Abstract][Full Text] [Related]
19. Focal liver lesions: SPIO-, gadolinium-, and ferucarbotran-enhanced dynamic T1-weighted and delayed T2-weighted MR imaging in rabbits.
Schnorr J; Wagner S; Abramjuk C; Drees R; Schink T; Schellenberger EA; Pilgrimm H; Hamm B; Taupitz M
Radiology; 2006 Jul; 240(1):90-100. PubMed ID: 16684917
[TBL] [Abstract][Full Text] [Related]
20. Enhancement of liver hemangiomas on T1-weighted MR SE images by superparamagnetic iron oxide particles.
Grangier C; Tourniaire J; Mentha G; Schiau R; Howarth N; Chachuat A; Grossholz M; Terrier F
J Comput Assist Tomogr; 1994; 18(6):888-96. PubMed ID: 7962795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
